| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |